Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Obstetrics and Gynecology

Pregnancy- and Lactation-Associated Osteoporosis (PLO)

At a Glance

Pregnancy- and lactation-associated osteoporosis is rare but can cause sudden severe back pain and multiple spinal fractures late in pregnancy or while breastfeeding. Diagnosis and treatment should be individualized, especially when considering weaning, medication, or another pregnancy.

Pregnancy- and Lactation-Associated Osteoporosis (PLO) is a rare and specific condition where bones become unusually fragile during late pregnancy or shortly after giving birth [1][2]. While it is normal for a mother’s body to move some calcium from her bones to her baby, women with PLO experience bone loss so severe that it leads to fragility fractures, most commonly in the spine [3][4].

For many women, the first sign of PLO is sudden, debilitating back pain that is often mistakenly dismissed as “normal” pregnancy or postpartum discomfort [5][6].

When and How it Presents

PLO typically appears in the third trimester of pregnancy or in the early months of breastfeeding [1][7].

  • The Main Symptom: Acute, severe lower or middle back pain that makes it difficult to stand, walk, or care for a newborn [3][7].
  • The Fracture Pattern: Unlike other forms of osteoporosis, PLO often involves multiple vertebral compression fractures (collapses in the bones of the spine) occurring at once [8][9]. Some women may experience a “cascade” of several fractures in a short period [9].

The Diagnostic Path

Because imaging and treatment must be safe for both mother and baby, the diagnostic process depends on your stage:

  • During Pregnancy: If you have severe back pain while pregnant, noncontrast MRI is often useful for detecting acute vertebral injury safely. It is considered highly effective for detecting swelling and collapse, but radiographs (X-rays) or other imaging may be medically appropriate and should not be withheld when needed. Gadolinium contrast is generally avoided unless essential [1][10].
  • Postpartum: After delivery, a DXA scan is used to measure bone mineral density (BMD). Postpartum DXA can show physiologic lactation-associated bone loss, so a low Z-score alone does not diagnose PLO—the diagnosis depends primarily on the clinical fracture pattern and exclusion of other causes [1][11].

Doctors will also run blood tests to ensure there isn’t another secondary cause—like a thyroid issue or vitamin D deficiency—contributing to the bone loss [1][12].

Immediate Management and Weaning

The first priority in treating PLO is reducing pain and preventing further fractures.

  • Weaning Considerations: Breastfeeding naturally increases “bone resorption” (the process of the body breaking down bone to release calcium) [13]. Because of this, weaning is often discussed in PLO, but it is not an automatic treatment for every patient. It is an individualized decision requiring obstetric, bone, infant-feeding, and lactation support [1][3].
  • Nutrition and Support: Patients should meet age- and pregnancy-appropriate calcium requirements and correct documented vitamin D deficiency under medical supervision rather than automatically starting high doses, which can cause kidney stones or hypercalcemia [1][11].
  • Medications: In severe cases, doctors may discuss “off-label” medications to build bone density. However, because some drugs (like bisphosphonates) can stay in the bone for years and potentially affect future pregnancies, these are used very cautiously in women who want to have more children [14][3].

Long-Term Outlook and Future Pregnancies

The prognosis for women with PLO is generally positive. Many women see a significant and natural increase in their bone density once they stop breastfeeding and their hormone levels return to a non-pregnant state [15][5].

However, the risk of recurrence is an important consideration:

  • Recurrence Risk: About 7% to 28% of women with PLO in some small studies experienced another fracture in a subsequent pregnancy [5]. This range is uncertain, and counseling regarding future pregnancies must be individualized.
  • Predicting Risk: Women who had multiple fractures during their first experience with PLO may be at a higher risk for recurrence than those who only had one [16].

If you are planning a future pregnancy, it is vital to have an individualized plan in place with a bone specialist (endocrinologist or rheumatologist) to monitor your density and ensure you have the best possible support for your skeletal health [1][5].

Common questions in this guide

What is pregnancy- and lactation-associated osteoporosis, and when does it happen?
Pregnancy- and lactation-associated osteoporosis (PLO) is a rare condition in which bones become unusually fragile during late pregnancy or soon after delivery. It often causes fragility fractures in the spine, sometimes several vertebral compression fractures at once.
Could severe back pain after pregnancy be a sign of PLO?
Yes. Sudden, severe lower or middle back pain during the third trimester or early months of breastfeeding—especially pain that makes standing, walking, or caring for a newborn difficult—should be evaluated promptly because spinal fractures can be mistaken for normal pregnancy or postpartum discomfort.
How do doctors test for PLO during pregnancy and after delivery?
During pregnancy, a noncontrast MRI can help detect swelling or collapse from a vertebral injury, and medically necessary X-rays should not be withheld; gadolinium contrast is usually avoided unless essential. After delivery, a DXA scan measures bone density, but a low Z-score alone does not prove PLO, so doctors also consider the fracture pattern and blood tests for other causes such as thyroid problems or vitamin D deficiency.
Do I have to stop breastfeeding if I have PLO?
Not necessarily. Breastfeeding increases bone breakdown to release calcium, so weaning is often discussed, but the decision is individualized based on fractures, bone health, infant-feeding goals, and advice from obstetric, bone, and lactation professionals.
What treatments might be considered for pregnancy- and lactation-associated osteoporosis?
Care focuses first on controlling pain and preventing more fractures, while meeting appropriate calcium needs and correcting documented vitamin D deficiency under medical supervision. In severe cases, clinicians may discuss off-label bone-building medicines such as teriparatide; bisphosphonates require particular caution because they can remain in bone for years and may matter for future pregnancies.
Can PLO happen again in a future pregnancy?
Another fracture has been reported in about 7% to 28% of women in some small studies, so the exact recurrence risk is uncertain. A history of multiple fractures may indicate higher risk, and anyone considering another pregnancy should make an individualized monitoring and treatment plan with an endocrinologist or rheumatologist.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my symptoms and timing, do I meet the clinical criteria for Pregnancy- and Lactation-Associated Osteoporosis (PLO)?
  2. 2.How many vertebral fractures were identified on my imaging, and at which levels of my spine?
  3. 3.Given the severity of my bone loss and fractures, what is your recommendation regarding breastfeeding or weaning, and can we involve a lactation consultant?
  4. 4.What are the risks and benefits of using bone-building medications like teriparatide versus conservative management with calcium and vitamin D?
  5. 5.If we consider medications like bisphosphonates, how might they affect my health and the health of a future baby in a subsequent pregnancy?
  6. 6.How should we monitor my bone density and fracture risk over the next year?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Pregnancy- and lactation-associated osteoporosis: A position statement of the IAPM, IOF, ECTS, ESCEO, IMS, and EMAS.

    Hadji P, Athanasiadis A, Brandi ML, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2026; doi:10.1002/ijgo.71203.

    PMID: 42464584
  2. 2

    Pregnancy- and lactation-associated osteoporosis with vertebral fractures: a systematic review.

    Qian Y, Wang L, Yu L, Huang W

    BMC musculoskeletal disorders 2021; (22(1)):926 doi:10.1186/s12891-021-04776-7.

    PMID: 34732196
  3. 3

    Teriparatide Treatment in Patients with Pregnancy- and Lactation-Associated Osteoporosis.

    Lampropoulou-Adamidou K, Trovas G, Triantafyllopoulos IK, et al.

    Calcified tissue international 2021; (109(5)):554-562 doi:10.1007/s00223-021-00871-y.

    PMID: 34132853
  4. 4

    HR-pQCT reveals marked trabecular and cortical structural deficits in women with pregnancy and lactation-associated osteoporosis (PLO).

    Agarwal S, El-Najjar D, Kondapalli A, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2024; (40(1)):38-49 doi:10.1093/jbmr/zjae167.

    PMID: 39423251
  5. 5

    Pregnancy and Lactation Associated Osteoporosis: A Systematic Review.

    Issa Z, Saad R, Lama Y, et al.

    Calcified tissue international 2026; (117(1)).

    PMID: 41848844
  6. 6

    Pregnancy and Lactation-Associated Osteoporosis Successfully Treated with Romosozumab: A Case Report.

    Kaneuchi Y, Iwabuchi M, Hakozaki M, et al.

    Medicina (Kaunas, Lithuania) 2022; (59(1)) doi:10.3390/medicina59010019.

    PMID: 36676643
  7. 7

    Pregnancy-associated osteoporosis: a case-control study.

    Hadji P, Boekhoff J, Hahn M, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2017; (28(4)):1393-1399 doi:10.1007/s00198-016-3897-8.

    PMID: 28074248
  8. 8

    Women With Pregnancy and Lactation-Associated Osteoporosis (PLO) Have Low Bone Remodeling Rates at the Tissue Level.

    Cohen A, Kamanda-Kosseh M, Dempster DW, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2019; (34(9)):1552-1561 doi:10.1002/jbmr.3750.

    PMID: 31348548
  9. 9

    Pregnancy and Lactation Associated Bone Fragility.

    Kovacs CS

    Journal of the Endocrine Society 2025; (9(9)):bvaf126 doi:10.1210/jendso/bvaf126.

    PMID: 40837111
  10. 10

    Bone metabolism and osteoporosis during pregnancy and lactation.

    Lujano-Negrete AY, Rodríguez-Ruiz MC, Skinner-Taylor CM, et al.

    Archives of osteoporosis 2022; (17(1)):36 doi:10.1007/s11657-022-01077-x.

    PMID: 35182221
  11. 11

    Bridging the Gap: Pregnancy-And Lactation-Associated Osteoporosis.

    Carsote M, Turturea MR, Valea A, et al.

    Diagnostics (Basel, Switzerland) 2023; (13(9)) doi:10.3390/diagnostics13091615.

    PMID: 37175006
  12. 12

    Osteoporosis in premenopausal women.

    Peris P

    Medicina clinica 2025; (164(10)):106940 doi:10.1016/j.medcli.2025.106940.

    PMID: 40267754
  13. 13

    Changes in bone metabolic profile associated with pregnancy or lactation.

    Miyamoto T, Miyakoshi K, Sato Y, et al.

    Scientific reports 2019; (9(1)):6787 doi:10.1038/s41598-019-43049-1.

    PMID: 31086225
  14. 14

    Comparative Effectiveness of Therapeutic Interventions in Pregnancy and Lactation-Associated Osteoporosis: A Systematic Review and Meta-analysis.

    Anagnostis P, Lampropoulou-Adamidou K, Bosdou JK, et al.

    The Journal of clinical endocrinology and metabolism 2024; (109(3)):879-901 doi:10.1210/clinem/dgad548.

    PMID: 37708365
  15. 15

    Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.

    Kyvernitakis I, Reuter TC, Hellmeyer L, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2018; (29(1)):135-142 doi:10.1007/s00198-017-4239-1.

    PMID: 28965212
  16. 16

    Long-term outcome of patients with pregnancy and lactation-associated osteoporosis (PLO) with a particular focus on quality of life.

    Gehlen M, Lazarescu AD, Hinz C, et al.

    Clinical rheumatology 2019; (38(12)):3575-3583 doi:10.1007/s10067-019-04758-0.

    PMID: 31468224

This page is for informational purposes only and does not constitute medical advice. Severe back pain during pregnancy or after delivery should be evaluated promptly by an obstetric or bone-health clinician.

Get notified when new evidence is published on premenopausal osteoporosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.